Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kozuru

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
American Journal of Hematology|October 10, 1998
Successful treatment of a patient with cardiac lymphoma who presented with a complete atrioventricular blockM Nagano, N Uike, J Suzumiya, et al.
Leukemia Research|August 1, 1997
T-stem cell leukemia/lymphoma with both myeloid lineage conversion and T-specific delta recombinationM Nagano, N Kimura, T Akiyoshi, et al.
British Journal of Haematology|June 14, 2001
A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303Y Yamada, M Tomonaga, H Fukuda, et al.
Japanese Journal of Clinical Oncology|May 8, 2000
Alternating combination chemotherapy C-MOPP (cyclophosphamide, vincristine, procarbazine, prednisone) and ABVd (adriamycin, bleomycin, vinblastine, dacarbazine) in clinical stage II-IV Hodgkin's disease: a multicenter phase II study (JCOG 8905). The Lymphoma Study Group of the Japan Clinical Oncology GroupT Takenaka, C Mikuni, A Miura, et al.
Japanese Journal of Clinical Oncology|September 2, 1999
Long-term follow-up results of adult patients with acute lymphocytic leukemia or lymphoblastic lymphoma treated with short-term, alternating non-cross-resistant chemotherapy: Japan Clinical Oncology Group Study 8702. Lymphoma Study GroupT Kobayashi, K Tobinai, M Shimoyama, et al.
The Japanese Journal of Antibiotics|December 1, 1996
[Comparison between monotherapy with imipenem/cilastatin sodium (IPM/CS) and combinations of IPM/CS and other drugs for treating bacterial infections in patients with hematopoietic disorders]Y Sawae, Y Niho, T Okamura, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
American Journal of Hematology|October 10, 1998
Successful treatment of a patient with cardiac lymphoma who presented with a complete atrioventricular blockM Nagano, N Uike, J Suzumiya, et al.
Leukemia Research|August 1, 1997
T-stem cell leukemia/lymphoma with both myeloid lineage conversion and T-specific delta recombinationM Nagano, N Kimura, T Akiyoshi, et al.
British Journal of Haematology|June 14, 2001
A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303Y Yamada, M Tomonaga, H Fukuda, et al.
Japanese Journal of Clinical Oncology|May 8, 2000
Alternating combination chemotherapy C-MOPP (cyclophosphamide, vincristine, procarbazine, prednisone) and ABVd (adriamycin, bleomycin, vinblastine, dacarbazine) in clinical stage II-IV Hodgkin's disease: a multicenter phase II study (JCOG 8905). The Lymphoma Study Group of the Japan Clinical Oncology GroupT Takenaka, C Mikuni, A Miura, et al.
Japanese Journal of Clinical Oncology|September 2, 1999
Long-term follow-up results of adult patients with acute lymphocytic leukemia or lymphoblastic lymphoma treated with short-term, alternating non-cross-resistant chemotherapy: Japan Clinical Oncology Group Study 8702. Lymphoma Study GroupT Kobayashi, K Tobinai, M Shimoyama, et al.
The Japanese Journal of Antibiotics|December 1, 1996
[Comparison between monotherapy with imipenem/cilastatin sodium (IPM/CS) and combinations of IPM/CS and other drugs for treating bacterial infections in patients with hematopoietic disorders]Y Sawae, Y Niho, T Okamura, et al.
Pageof 8